These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 34139698)

  • 1. Polypharmacy and Frailty among Hemodialysis Patients.
    Kimura H; Kalantar-Zadeh K; Rhee CM; Streja E; Sy J
    Nephron; 2021; 145(6):624-632. PubMed ID: 34139698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study.
    Veronese N; Stubbs B; Noale M; Solmi M; Pilotto A; Vaona A; Demurtas J; Mueller C; Huntley J; Crepaldi G; Maggi S
    J Am Med Dir Assoc; 2017 Jul; 18(7):624-628. PubMed ID: 28396180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal associations of polypharmacy and frailty with major cardiovascular events and mortality among more than half a million middle-aged participants of the UK Biobank.
    Chen LJ; Sha S; Brenner H; Schöttker B
    Maturitas; 2024 Jul; 185():107998. PubMed ID: 38678818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect modification of polypharmacy on incident frailty by chronic kidney disease in older adults.
    Mielke N; Barghouth MH; Fietz AK; Villain C; Bothe T; Ebert N; Schaeffner E
    BMC Geriatr; 2024 Apr; 24(1):335. PubMed ID: 38609867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frailty in patients on dialysis.
    Chan GC; Kalantar-Zadeh K; Ng JK; Tian N; Burns A; Chow KM; Szeto CC; Li PK
    Kidney Int; 2024 Jul; 106(1):35-49. PubMed ID: 38705274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frailty syndrome and end-stage kidney disease outcomes at a Latin American dialysis center.
    Moreno LD; Ruiz CE; Urrego JC; Cadena MO; Maldonado SJ; Niño DA; Maldonado A
    Biomedica; 2023 Dec; 43(Sp. 3):21-29. PubMed ID: 38207151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy and frailty among persons with HIV.
    Sung M; Gordon K; Edelman EJ; Akgün KM; Oursler KK; Justice AC
    AIDS Care; 2021 Nov; 33(11):1492-1499. PubMed ID: 32880183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacy Predicts Onset and Transition of Frailty, Malnutrition, and Adverse Outcomes in Peritoneal Dialysis Patient.
    Chan GC; Ng JK; Chow KM; Cheng PM; Law MC; Leung CB; Li PK; Szeto CC
    J Nutr Health Aging; 2022; 26(12):1054-1060. PubMed ID: 36519768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis.
    Kitamura M; Yamaguchi K; Ota Y; Notomi S; Komine M; Etoh R; Harada T; Funakoshi S; Mukae H; Nishino T
    Sci Rep; 2021 Dec; 11(1):24238. PubMed ID: 34930934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of degree of polypharmacy before and after among hospitalised internal medicine patients and clinical outcomes: a retrospective, population-based cohort study.
    Jonsdottir F; Blondal AB; Gudmundsson A; Bates I; Stevenson JM; Sigurdsson MI
    BMJ Open; 2024 Mar; 14(3):e078890. PubMed ID: 38548367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the role of vascular frailty in understanding blood pressure variability and mortality risk among end-stage kidney disease patients undergoing hemodialysis.
    Lee SY; Chao CT
    Clin Cardiol; 2024 May; 47(5):e24281. PubMed ID: 38738580
    [No Abstract]   [Full Text] [Related]  

  • 12. Frailty may blunt the therapeutic efficacy and complication risk through multi-pronged mechanisms.
    Chao CT
    Can J Cardiol; 2024 Jul; ():. PubMed ID: 39038651
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Frailty and Polypharmacy.
    Rolland Y; Morley JE
    J Nutr Health Aging; 2016; 20(6):645-6. PubMed ID: 27273354
    [No Abstract]   [Full Text] [Related]  

  • 14. Precision medicine in diabetic nephropathy and chronic kidney disease.
    Fliser D; Wanner C
    Nephrol Dial Transplant; 2021 Jun; 36(Suppl 2):10-13. PubMed ID: 34153982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose Homeostasis, Hypoglycemia, and the Burnt-Out Diabetes Phenomenon in Kidney Disease.
    Rhee CM; Kovesdy CP; Kalantar-Zadeh K
    Semin Nephrol; 2021 Mar; 41(2):96-103. PubMed ID: 34140100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel roles of HIF-PHIs in chronic kidney disease: the link between iron metabolism, kidney function, and FGF23.
    Ikeda Y
    Kidney Int; 2021 Jul; 100(1):14-16. PubMed ID: 34154707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narrative Review: Clinical Implications and Assessment of Frailty in Patients With Advanced CKD.
    Kennard AL; Glasgow NJ; Rainsford SE; Talaulikar GS
    Kidney Int Rep; 2024 Apr; 9(4):791-806. PubMed ID: 38765572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram model for predicting frailty of patients with hematologic malignancies - A cross-sectional survey.
    Luo S; Zhao H; Gan X; He Y; Wu C; Ying Y
    Asia Pac J Oncol Nurs; 2023 Nov; 10(11):100307. PubMed ID: 37928413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frailty as a dynamic process in a diverse cohort of older persons with dialysis-dependent CKD.
    Kutner NG; Zhang R
    Front Nephrol; 2023; 3():1031338. PubMed ID: 37675341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of frailty assessment instruments in nephrology populations: a scoping review.
    Kennard AL; Rainsford S; Glasgow NJ; Talaulikar GS
    BMC Geriatr; 2023 Jul; 23(1):449. PubMed ID: 37479978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.